IL HB0239 | 2017-2018 | 100th General Assembly

Status

Spectrum: Partisan Bill (Democrat 6-0)
Status: Introduced on January 11 2017 - 25% progression
Action: 2017-03-31 - Rule 19(a) / Re-referred to Rules Committee
Pending: House Rules Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Amends the Illinois Food, Drug and Cosmetic Act. Requires manufacturers of brand name or generic prescription drugs to notify State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly of specified increases in drug prices at least 60 days before such increase and the cost of specified new prescription drugs within 3 days after approval by the U.S. Food and Drug Administration. Provides that within 30 days after such notifications, prescription drug manufacturers shall report specified information to State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly. Provides that failure to report such information shall result in a specified civil penalty. Requires the General Assembly to conduct an annual public hearing on aggregate trends in prescription drug pricing. Provides that if the manufacturer of a prescription drug or its agent meets or otherwise communicates with a prescriber for the purpose of marketing a drug, then the manufacturer or its agent shall disclose to the prescriber if any ingredient in the drug it is marketing is known to pose a risk of dependency in humans. Makes other changes.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

DRUG MANUFACTURER-DISCLOSURES

Sponsors


History

DateChamberAction
2017-03-31HouseRule 19(a) / Re-referred to Rules Committee
2017-03-14HouseAdded Co-Sponsor Rep. Natalie A. Manley
2017-02-28HouseAdded Chief Co-Sponsor Rep. Emanuel Chris Welch
2017-02-23HouseAdded Co-Sponsor Rep. Camille Y. Lilly
2017-01-31HouseAdded Co-Sponsor Rep. Thaddeus Jones
2017-01-31HouseAdded Co-Sponsor Rep. Silvana Tabares
2017-01-25HouseAssigned to Health Care Licenses Committee
2017-01-11HouseReferred to Rules Committee
2017-01-11HouseFirst Reading
2016-12-15HousePrefiled with Clerk by Rep. Mary E. Flowers

Code Citations

ChapterArticleSectionCitation TypeStatute Text
41062016.2New CodeSee Bill Text
41062016.3New CodeSee Bill Text

Illinois State Sources


Bill Comments

feedback